Join Zoom Meeting
https://mc-meet.zoom.us/j/95869608121?pwd=NG9GaG5JWE44eGpSckdRWHFSNnVkUT09

Meeting ID: 958 6960 8121
Passcode: 636276

Michael S. Rafii, M.D., Ph.D.
"Down Syndrome and Alzheimer’s Disease: From Historical Insights to Future Therapies"

Learning Objectives
Upon conclusion of this activity, participants will be able to:

• Recognize the similarities between the progression of Down syndrome-related Alzheimer's disease and other forms of AD including autosomal dominant and sporadic forms.
• Discern the difference between Down syndrome related-Alzheimer's disease and other forms of AD including autosomal dominant and sporadic forms.
• Describe the natural history and biomarker trajectory of AD biomarkers in people with Down syndrome
• Describe why people with Down syndrome are at high risk of developing AD
• Describe current clinical trials for AD in people with DS

Dr. Rafii does have any relevant financial relationships to disclose and does intend to discuss any off-label/investigative use of Pharmaceuticals or Instruments. 

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.